Benign prostatic hyperplasia
- PMID: 39013719
- DOI: 10.1016/j.medcli.2024.04.014
Benign prostatic hyperplasia
Abstract
Benign prostatic hyperplasia (BPH) is a histopathologic definition associated with enlargement of the prostate gland that causes obstruction of the lower urinary tract and manifests clinically with characteristic symptoms that are what bring patients for consultation. Urinary tract symptoms are common, especially in an increasingly aging population. Diagnosis and the decision on when and how to treat depend on the patient's quality of life and objective clinical parameters. An individualized, risk-based approach is necessary to guide conservative, pharmacologic, or surgical treatment.
Keywords: Benign prostatic hyperplasia; Hiperplasia prostática benigna; Lower urinary tract symptoms; Resección transuretral de próstata; Síntomas del tracto urinario inferior; Transurethral resection of prostate.
Copyright © 2024 Elsevier España, S.L.U. All rights reserved.
Similar articles
-
Prostatic hydroablation (Aquablation): A new effective ultrasound guided robotic waterjet ablative surgery for treatment of benign prostatic hyperplasia.Arch Esp Urol. 2019 Oct;72(8):786-793. Arch Esp Urol. 2019. PMID: 31579037 English.
-
Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence.Actas Urol Esp. 2016 Jun;40(5):288-94. doi: 10.1016/j.acuro.2015.12.008. Epub 2016 Jan 25. Actas Urol Esp. 2016. PMID: 26823069 Review. English, Spanish.
-
Clinical application of the UroLift® prostatic urethral lift in Spain: consensus on the treatment of lower urinary tract symptoms associated with urinary flow obstruction and secondary to benign prostatic hyperplasia (BPH).Actas Urol Esp (Engl Ed). 2024 Dec;48(10):732-738. doi: 10.1016/j.acuroe.2024.09.004. Epub 2024 Sep 23. Actas Urol Esp (Engl Ed). 2024. PMID: 39321994 English, Spanish.
-
Association between interleukin-6 and lower urinary tract symptoms of benign prostatic hyperplasia.Rev Int Androl. 2023 Apr-Jun;21(2):100334. doi: 10.1016/j.androl.2021.10.002. Epub 2022 Oct 17. Rev Int Androl. 2023. PMID: 36266235
-
Multicenter study of the impact of Urolift® implantation in patients undergoing medical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.Actas Urol Esp (Engl Ed). 2025 May;49(4):501708. doi: 10.1016/j.acuroe.2025.501708. Epub 2025 Feb 11. Actas Urol Esp (Engl Ed). 2025. PMID: 39947294 English, Spanish.
Cited by
-
Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context.Glob Reg Health Technol Assess. 2025 Jul 22;12:177-185. doi: 10.33393/grhta.2025.3401. eCollection 2025 Jan-Dec. Glob Reg Health Technol Assess. 2025. PMID: 40698355 Free PMC article.
-
Unveiling therapeutic targets and preventive components for kidney insufficiency and blood stasis-type BPH: bridging metabolomics, network pharmacology and reverse screening.Front Pharmacol. 2025 Jun 19;16:1584766. doi: 10.3389/fphar.2025.1584766. eCollection 2025. Front Pharmacol. 2025. PMID: 40626307 Free PMC article.
-
Clinical Application Effect of Postoperative Nursing Intervention on Patients Undergoing Transurethral Prostatectomy: A Systematic Review and Meta-Analysis.Iran J Public Health. 2025 Feb;54(2):285-296. Iran J Public Health. 2025. PMID: 40225246 Free PMC article. Review.
-
The relationship between the triglyceride glucose-waist height ratio and benign prostatic hyperplasia in middle-aged and elderly adults: a nationwide cohort study.BMC Urol. 2025 Jul 3;25(1):153. doi: 10.1186/s12894-025-01844-1. BMC Urol. 2025. PMID: 40611225 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical